BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 15150112)

  • 21. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.
    Reichrath J; Rass K
    Adv Exp Med Biol; 2014; 810():208-33. PubMed ID: 25207368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
    Bolshakov S; Walker CM; Strom SS; Selvan MS; Clayman GL; El-Naggar A; Lippman SM; Kripke ML; Ananthaswamy HN
    Clin Cancer Res; 2003 Jan; 9(1):228-34. PubMed ID: 12538474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation.
    Stratigos AJ; Kapranos N; Petrakou E; Anastasiadou A; Pagouni A; Christofidou E; Petridis A; Papadopoulos O; Kokka E; Antoniou C; Georgala S; Katsambas AD
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):180-6. PubMed ID: 15752287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours.
    Dahmane N; Lee J; Robins P; Heller P; Ruiz i Altaba A
    Nature; 1997 Oct; 389(6653):876-81. PubMed ID: 9349822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Xeroderma pigmentosum.
    Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
    Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.
    Reifenberger J; Wolter M; Weber RG; Megahed M; Ruzicka T; Lichter P; Reifenberger G
    Cancer Res; 1998 May; 58(9):1798-803. PubMed ID: 9581815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of phenotype/genotype in a cohort of 23 xeroderma pigmentosum-variant patients reveals 12 new disease-causing POLH mutations.
    Opletalova K; Bourillon A; Yang W; Pouvelle C; Armier J; Despras E; Ludovic M; Mateus C; Robert C; Kannouche P; Soufir N; Sarasin A
    Hum Mutat; 2014 Jan; 35(1):117-28. PubMed ID: 24130121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms.
    Lacour JP
    Br J Dermatol; 2002 Apr; 146 Suppl 61():17-9. PubMed ID: 11966727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activating Smoothened mutations in sporadic basal-cell carcinoma.
    Xie J; Murone M; Luoh SM; Ryan A; Gu Q; Zhang C; Bonifas JM; Lam CW; Hynes M; Goddard A; Rosenthal A; Epstein EH; de Sauvage FJ
    Nature; 1998 Jan; 391(6662):90-2. PubMed ID: 9422511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels.
    Chavanne F; Broughton BC; Pietra D; Nardo T; Browitt A; Lehmann AR; Stefanini M
    Cancer Res; 2000 Apr; 60(7):1974-82. PubMed ID: 10766188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. XPA-deficiency in hairless mice causes a shift in skin tumor types and mutational target genes after exposure to low doses of U.V.B.
    de Vries A; Berg RJ; Wijnhoven S; Westerman A; Wester PW; van Kreijl CF; Capel PJ; de Gruijl FR; van Kranen HJ; van Steeg H
    Oncogene; 1998 Apr; 16(17):2205-12. PubMed ID: 9619829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activated oncogenes in human skin tumors from a repair-deficient syndrome, xeroderma pigmentosum.
    Suarez HG; Daya-Grosjean L; Schlaifer D; Nardeux P; Renault G; Bos JL; Sarasin A
    Cancer Res; 1989 Mar; 49(5):1223-8. PubMed ID: 2645047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of human papillomavirus in skin tumors from repair deficient xeroderma pigmentosum patients.
    Luron L; Avril MF; Sarasin A; Daya-Grosjean L
    Cancer Lett; 2007 Jun; 250(2):213-9. PubMed ID: 17126994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TP53 mutations in human skin cancers.
    Giglia-Mari G; Sarasin A
    Hum Mutat; 2003 Mar; 21(3):217-28. PubMed ID: 12619107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative susceptibilities of XPA knockout mice and their heterozygous and wild-type littermates to UVB-induced skin cancer.
    Berg RJ; de Vries A; van Steeg H; de Gruijl FR
    Cancer Res; 1997 Feb; 57(4):581-4. PubMed ID: 9044829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of a sonic hedgehog signal transducer, hedgehog-interacting protein, by human basal cell carcinoma.
    Tojo M; Kiyosawa H; Iwatsuki K; Kaneko F
    Br J Dermatol; 2002 Jan; 146(1):69-73. PubMed ID: 11841368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer.
    de Gruijl FR; van Kranen HJ; Mullenders LH
    J Photochem Photobiol B; 2001 Oct; 63(1-3):19-27. PubMed ID: 11684448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clones of normal keratinocytes and a variety of simultaneously present epidermal neoplastic lesions contain a multitude of p53 gene mutations in a xeroderma pigmentosum patient.
    Williams C; Pontén F; Ahmadian A; Ren ZP; Ling G; Rollman O; Ljung A; Jaspers NG; Uhlén M; Lundeberg J; Pontén J
    Cancer Res; 1998 Jun; 58(11):2449-55. PubMed ID: 9622088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Report of three sisters with XP-E, a rare xeroderma pigmentosum complementation group.
    Fischer E; Schnyder UW; Jung EG
    Photodermatol; 1984 Oct; 1(5):232-6. PubMed ID: 6531300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative genomics on Sonic hedgehog orthologs.
    Katoh Y; Katoh M
    Oncol Rep; 2005 Oct; 14(4):1087-90. PubMed ID: 16142377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.